Johnson & Johnson Inc. of New Brunswick, a medical-products company, agreed Monday to pay $428.26 million for outstanding stock of Omrix Biopharmaceuticals Inc. of New York, a pharmaceutical company. J&J is represented by Cravath, Swaine & Moore, Jones Day and Weil Gotschal & Manges, all in New York. Omrix is represented by Skadden, Arps, Slate, Meagher & Flom in New York.
Hoffmann-La Roche To Pay $50M for Memory Pharmaceutical
Hoffmann-La Roche Inc., a pharmaceutical company based in Basel, Switzerland, with U.S. headquarters in Nutley, announced Tuesday it would pay $50.17 million for outstanding common stock of Memory Pharmaceuticals of Montvale, a biopharmaceutical company. Hoffmann-La Roche is represented by Marc Williams at Davis Polk & Wardwell in New York and Memory by J.D. Weinberg at Covington & Burling in New York.
ISO Acquires Consulting Firm
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
